Hemodialysis Market Growth, Demand and Challenges of the Key Industry Players 2024-32


MARKETRESEARCH

Uploaded on May 8, 2024

According to the latest research report by IMARC Group, The global hemodialysis market size reached US$ 90.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/hemodialysis-market

Comments

                     

Hemodialysis Market Growth, Demand and Challenges of the Key Industry Players 2024-32

Global Hemodialysis Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " H e m o d i a l y s i s M a r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 - 2 0 3 2 , " t h e g l o b a l h e m o d i a l y s i s m a r k e t s i z e r e a c h e d U S $ 9 0 . 7 B i l l i o n i n 2 0 2 3 . H e m o d i a l y s i s i s a t r e a t m e n t o p t i o n f o r i n d i v i d u a l s w i t h e n d - s t a g e r e n a l d i s e a s e ( E S R D ) o r a c u t e k i d n e y i n j u r y . I t i n v o l v e s t h e p u r i f i c a t i o n o f b l o o d u s i n g a d i a l y s i s m a c h i n e , s e r v i n g a s Report a n a r t i f i c i a l k i d n e y . I t p r i m a r i l y r e m o v e s w a s t e p r o d u c t s , e x c e s s f l u i d , a n d t o x i n s f r o m t h e b l o o d s t r e a m , t h e r e b y r e s t o r i n g t h e b o d y ' s c h e m i c a l b a l a n c e . D u r i n g h e m o d i a l y s i s , t h e p a t i e n t ' s b l o o d i s d i v e r t e d t h r o u g h a d i a l y z e r , a f i l t e r - l i k e c o m p o n e n t w i t h i n t h e d i a l y s i s Highlight and m a c h i n e . T h e d i a l y z e r c o n s i s t s o f a s e m i p e r m e a b l e m e m b r a n e t h a t a l l o w s t h e p a s s a g e o f w a s t e p r o d u c t s a n d e x c e s s f l u i d w h i l e r e t a i n i n g v i t a l b l o o d c o m p o n e n t s . O n e o f t h e p r i m a r y a d v a n t a g e s o f h e m o d i a l y s i s i s i t s a b i l i t y t o e f f i c i e n t l y e l i m i n a t e w a s t e Description p r o d u c t s a n d r e g u l a t e f l u i d b a l a n c e , p r o v i d i n g r e l i e f f r o m s y m p t o m s a s s o c i a t e d w i t h k i d n e y f a i l u r e . F u r t h e r m o r e , i t c a n b e p e r f o r m e d a t s p e c i a l i z e d d i a l y s i s c e n t e r s o r h o m e , o f f e r i n g f l e x i b i l i t y a n d c o n v e n i e n c e f o r p a t i e n t s . I n c o m p a r i s o n t o p e r i t o n e a l d i a l y s i s , i t p r o v i d e s m o r e r a p i d a n d e f f e c t i v e r e m o v a l o f t o x i n s f r o m t h e b o d y . C u r r e n t l y , t h e r e a r e d i f f e r e n t t y p e s o f h e m o d i a l y s i s t r e a t m e n t a v a i l a b l e , i n c l u d i n g c o n v e n t i o n a l h e m o d i a l y s i s a n d h e m o d i a f i l t r a t i o n . R e q u e s t f o r a P D F s a m p l e o f t h i s r e p o r t : h t t p s : / / w w w . i m a r c g r o u p . c o m / h e m o d i a l y s i s - m a r k e t / r e q u e s t s a m p l e Report Description G l o b a l H e m o d i a l y s i s M a r k e t T r e n d s : T h e g l o b a l h e m o d i a l y s i s m a r k e t i s p r i m a r i l y i n f l u e n c e d b y t h e r i s i n g p r e v a l e n c e o f c h r o n i c k i d n e y d i s e a s e s ( C K D ) a n d e n d - s t a g e r e n a l d i s e a s e ( E S R D ) a c r o s s t h e g l o b e . T h i s i s f u r t h e r s u p p o r t e d b y t h e i n c r e a s i n g g e r i a t r i c p o p u l a t i o n m o r e s u s c e p t i b l e t o s u c h a i l m e n t s . M o r e o v e r , t h e g r o w i n g n u m b e r o f d i a l y s i s c e n t e r s a n d s i g n i f i c a n t a d v a n c e m e n t s i n h e m o d i a l y s i s t e c h n o l o g i e s , s u c h a s t h e i n t r o d u c t i o n o f h i g h - f l u x d i a l y z e r s a n d o n l i n e h e m o d i a f i l t r a t i o n s y s t e m s , a r e b o o s t i n g t h e m a r k e t g r o w t h . T h e r i s i n g h e a l t h c a r e e x p e n d i t u r e a n d a v a i l a b i l i t y o f f a v o r a b l e r e i m b u r s e m e n t p o l i c i e s f o r d i a l y s i s t r e a t m e n t s a r e a l s o p r o p e l l i n g t h e m a r k e t g r o w t h . A d d i t i o n a l l y , t h e s u r g i n g a w a r e n e s s a b o u t r e n a l c a r e , t h e a v a i l a b i l i t y o f p o r t a b l e a n d h o m e h e m o d i a l y s i s d e v i c e s , a n d t h e g r o w i n g a d o p t i o n o f t e l e m e d i c i n e f o r r e m o t e m o n i t o r i n g o f d i a l y s i s p a t i e n t s a r e c o n t r i b u t i n g t o t h e m a r k e t g r o w t h . M o r e o v e r , b u r g e o n i n g i n v e s t m e n t s i n r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a c t i v i t i e s t o i m p r o v e t h e e f f i c a c y a n d s a f e t y o f h e m o d i a l y s i s p r o c e d u r e s , a l o n g w i t h t h e e m e r g e n c e o f w e a r a b l e a r t i f i c i a l k i d n e y s a n d b i o e n g i n e e r e d b l o o d v e s s e l s , a r e p r o v i d i n g a n i m p e t u s t o t h e m a r k e t g r o w t h . F u r t h e r m o r e , t h e i n t e g r a t i o n o f a r t i f i c i a l i n t e l l i g e n c e ( A I ) i n h e m o d i a l y s i s m a c h i n e s i s c r e a t i n g a p o s i t i v e o u t l o o k f o r t h e m a r k e t . A p a r t f r o m t h i s , t h e r i s i n g p r e v a l e n c e o f d i a b e t e s a n d h y p e r t e n s i o n , t h e i n c r e a s i n g d e m a n d f o r h o m e - b a s e d h e m o d i a l y s i s , a n d s u r g i n g m e r g e r s a n d a c q u i s i t i o n s a c t i v i t i e s a m o n g k e y m a r k e t p l a y e r s a r e f a v o r i n g t h e m a r k e t g r o w t h . L o o k i n g f o r w a r d , t h e m a r k e t v a l u e i s p r o j e c t e d t o r e a c h U S $ 1 2 6 . 7 B i l l i o n b y 2 0 3 2 , e x p a n d i n g a t a C A G R o f 3 . 7 % d u r i n g 2 0 2 4 - 2 0 3 2 . V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / h e m o d i a l y s i s - m a r k e t Breakup by Segment: • Hemodialys is Product o Machines o Dialyzers o Others • Hemodialys is Service Report o In-center Services o Home Services Segmentation   Breakup by Modality: • Convent ional Hemodialys is • Short Dai ly Hemodialys is • Nocturnal Hemodialys is Breakup by End-User: • Hospitals • Independent Dialysis Centres • Others Report Breakup by Region: • Asia Pacifi c Segmentation • Europe • North America • Middle East and Afr ica • Latin America • Baxter Internat ional • Asahi Kasei Corporat ion • B. Barun Melsungen • DaVita • Cantel Medica l Corporat ion Competitive • Fresenius Medical Care Landscape • Nipro Corporat ion • Rockwel l Medica l with Key • Medivators Players • Toray Medica l Company Ltd. • Nikkiso Co. Ltd. • Surni Group • Gambro • Satel l i te Hea lthcare Inc. • Renacon Pharma Ltd. How big is the global hemodialysis market? What is the expected growth rate of the global hemodialysis market during 2024-2032? What are the key factors driving the global Key hemodialysis market? Questions What has been the impact of COVID-19 on the global hemodialysis market? Answered in What is the breakup of the global hemodialysis the Report market based on the segment? What is the breakup of the global hemodialysis market based on the modality? What are the key regions in the global hemodialysis market? Who are the key players/companies in the global hemodialysis market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l H e m o d i a l y s i s M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t B r e a k u p b y S e g m e n t 5 . 4 . 1 M a r k e t B r e a k u p b y P r o d u c t 5 . 4 . 2 M a r k e t B r e a k u p b y S e r v i c e 5 . 5 M a r k e t B r e a k u p b y M o d a l i t y 5 . 6 M a r k e t B r e a k u p b y E n d - U s e r 5 . 7 M a r k e t B r e a k u p b y R e g i o n 5 . 8 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y S e g m e n t 6 . 1 H e m o d i a l y s i s P r o d u c t 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t B r e a k u p b y P r o d u c t 6 M a r k e t B r e a k u p b y S e g m e n t 6 . 1 H e m o d i a l y s i s P r o d u c t 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t B r e a k u p b y P r o d u c t 6 . 1 . 2 . 1 M a c h i n e s 6 . 1 . 2 . 2 D i a l y z e r s 6 . 1 . 2 . 3 O t h e r s 6 . 1 . 3 M a r k e t F o r e c a s t 6 . 2 H e m o d i a l y s i s S e r v i c e 6 . 2 . 1 M a r k e t T r e n d s Table of 6 . 2 . 2 M a r k e t B r e a k u p b y S e r v i c e 6 . 2 . 2 . 1 I n - c e n t e r S e r v i c e s 6 . 2 . 2 . 2 H o m e S e r v i c e s 6 . 2 . 3 M a r k e t F o r e c a s t Contents 7 M a r k e t B r e a k u p b y M o d a l i t y 7 . 1 C o n v e n t i o n a l H e m o d i a l y s i s 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 S h o r t D a i l y H e m o d i a l y s i s 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t 7 . 3 N o c t u r n a l H e m o d i a l y s i s 7 . 3 . 1 M a r k e t T r e n d s 7 . 3 . 2 M a r k e t F o r e c a s t 8 M a r k e t B r e a k u p b y E n d - U s e r 8 . 1 H o s p i t a l s 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /h em o d ia l y s i s -m a rke t / t o c Partial List of Clients Partial List of Clients Disclaimer © 2024 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com +1-631-791-1145 [email protected] Stay With Us: